These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14178360)

  • 1. [PURIFICATION AND CONCENTRATION OF CL. PERFRINGENS TOXOID WITH THE USE OF NO ANION EXCHANGE RESIN].
    SAMSONOVA VS; DAVANKOV AB; LAUFER VM
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Feb; 41():98-102. PubMed ID: 14178360
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification of Clostridium toxoids.
    Buchowicz I; Hay M; Schiller B; Korbecki M; Sochańska R
    Acta Microbiol Pol; 1977; 26(3):285-94. PubMed ID: 70974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification of the toxoids of Cl. Perfringens and Cl. pedematiens using silicagel].
    Efimova NP; Tul'bovich EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):82-6. PubMed ID: 190831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha toxoid of Clostridium perfringens. I. Purification and toxoiding of alpha toxin of C. perfringens.
    Ito A
    Jpn J Med Sci Biol; 1968 Dec; 21(6):379-91. PubMed ID: 4306752
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Clostridium toxoids, especially of Clostridium perfringens toxoid, on mouse transplanted tumors.
    Sasaki T; Chihara G; Takasuka N; Suzuki S
    Gan; 1976 Apr; 67(2):275-7. PubMed ID: 184006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification of viruses with an anion exchange resin.
    LOGRIPPO GA
    Proc Soc Exp Biol Med; 1950 May; 74(1):208-11. PubMed ID: 15430436
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the passive hemagglutination test for the purpose of determining antibody levels following animal immunization with Cl. perfringens toxoid].
    Shemanova GF; Dmitrieva LN; Vlasova EV; Panteleev EI; Moshiashvili IIa
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Feb; (2):85-8. PubMed ID: 193324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Reference Preparations of Clostridium welchii (C. perfringens) beta and epsilon toxoids.
    Davidson I; Gray AK; Hebert CN; Lesslie IW
    Bull World Health Organ; 1978; 56(4):641-8. PubMed ID: 215337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
    Saleh N; Fathalla SI; Nabil R; Mosaad AA
    Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local structures of ions at ion-exchange resin/solution interface.
    Harada M; Okada T
    J Chromatogr A; 2005 Aug; 1085(1):3-7. PubMed ID: 16106840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of membrane separation methods in the production of Clostridium perfringens toxoid].
    Semenova VD; Nikolaeva AM; Efimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):32-6. PubMed ID: 9662794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of Clostridium perfringens recombinant β toxoid.
    Milach A; de los Santos JR; Turnes CG; Moreira AN; de Assis RA; Salvarani FM; Lobato FC; Conceição FR
    Anaerobe; 2012 Jun; 18(3):363-5. PubMed ID: 22306065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the resin (anion exchange resin) agglutination test in brucellosis. II. Resin agglutination tests on various kinds of serum].
    SUZUKI K
    Nihon Saikingaku Zasshi; 1961 Sep; 16():781-5. PubMed ID: 13918603
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyamine anion exchange resin in the management of peptic ulcer.
    BERGEN OM; GREENBERG A
    N Y State J Med; 1950 Jun; 50(12):1495-6. PubMed ID: 15423725
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.